Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation. (20th June 2013)
- Record Type:
- Journal Article
- Title:
- Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation. (20th June 2013)
- Main Title:
- Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation
- Authors:
- Dal Bó, Suzane
Pezzi, Annelise
Amorin, Bruna
Valim, Vanessa
Isabel Bittencourt, Rosane
Silla, Lucia - Other Names:
- Bosly A. Academic Editor.
Gatt A. Academic Editor. - Abstract:
- Abstract : The treatment strategy in multiple myeloma (MM) is to get complete remission followed by high-dose chemotherapy and autologous Hematopoietic Stem Cell Transplantation (HSCT). Neoplastic Plasma Cells (NPCs) are CD45 - / dim, CD38 + high, CD138 +, CD19 −, and CD56 + high in most cases. The description of this immunophenotype is of major importance as it leads to the correct identification of minimal residual disease (MRD). Samples from 44 Patients were analyzed prospectively in this study. We analyzed if the presence of MRD at three months after HSCT was predictive of relapse or death. There were 40 evaluable patients of whom 16/40 patients had MRD at three moths after HSCT and there were none in cytological relapse. The mean overall survival (OS) was 34 months and disease-free survival (RFS) was 28 months after HSCT. There was no significant difference in the log rank analysis comparing OS and the presence of MRD (P = 0, 611 ) and RFS (P = 0, 3106 ). Here, we demonstrate that three color flow cytometry (FCM) is more sensitive for MDR evaluation than cytological analyzes. However, based in our data we can not affirm that MRD is a good predictor of MM relapse or death. In conclusion, our results could be attributed to a short followup, small sample size, and over most to the inability of a three-color FCM to detect the NPC population.
- Is Part Of:
- ISRN hematology. Volume 2013(2013)
- Journal:
- ISRN hematology
- Issue:
- Volume 2013(2013)
- Issue Display:
- Volume 2013, Issue 2013 (2013)
- Year:
- 2013
- Volume:
- 2013
- Issue:
- 2013
- Issue Sort Value:
- 2013-2013-2013-0000
- Page Start:
- Page End:
- Publication Date:
- 2013-06-20
- Subjects:
- Hematology -- Periodicals
Hematologic Diseases
Hematology
Hematology
Electronic journals
Periodical
Periodicals
Fulltext
Internet Resources
Periodicals
616.15 - Journal URLs:
- https://www.hindawi.com/journals/isrn/contents/isrn.hematology/ ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/1638/ ↗ - DOI:
- 10.1155/2013/847672 ↗
- Languages:
- English
- ISSNs:
- 2090-441X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 24050.xml